Literature DB >> 12172724

Evidence of the subcommissural organ in humans and its association with hydrocephalus.

Marcelo Galarza1.   

Abstract

A group of structures in the human central nervous system (CNS) represents a noteworthy dilemma for the neuroscientist, particularly to the neuroanatomist. In this paper an attempt is made by extensive review of the literature to give an account of the significance of the subcommissural organ (SCO) in humans and its possible relationship with cerebrospinal fluid (CSF) disorders. The subcommissural organ is a gland located in the diencephalic plate caudal to the pineal organ that covers the anterior part of the posterior commissure. Histologically, it is a highly differentiated ependyma. After birth, the SCO undergoes regressive changes, and in the adult human only remnants of the specialized SCO cells can be found. The Reissner's fiber (RF) may be regarded as a pure secretory product of the SCO. Only a few vertebrate species have been reported to lack an RF, namely the bat, camel, chimpanzee, and man. Nonetheless, a successful immunoreaction against a proteinaceous compound of the fetal human SCO has been performed. Recently, new interest was elicited regarding SCO and its possible implication in the pathogenesis of hydrocephalus. The objective of this review is to bring into consideration the relevance of the SCO to the neurosurgical scenario.

Entities:  

Mesh:

Year:  2002        PMID: 12172724     DOI: 10.1007/s10143-002-0208-y

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  9 in total

1.  Pathways of cerebrospinal fluid outflow: a deeper understanding of resorption.

Authors:  Long Chen; Gavin Elias; Marina P Yostos; Bojan Stimec; Jean Fasel; Kieran Murphy
Journal:  Neuroradiology       Date:  2014-11-16       Impact factor: 2.804

2.  Neuropeptide signaling and hydrocephalus: SCO with the flow.

Authors:  David J Picketts
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 3.  Genetic animal modeling for idiopathic scoliosis research: history and considerations.

Authors:  Elizabeth A Terhune; Anna M Monley; Melissa T Cuevas; Cambria I Wethey; Ryan S Gray; Nancy Hadley-Miller
Journal:  Spine Deform       Date:  2022-04-16

Review 4.  MR assessment of pediatric hydrocephalus: a road map.

Authors:  Charles Raybaud
Journal:  Childs Nerv Syst       Date:  2015-09-04       Impact factor: 1.475

5.  Expression of the human PAC1 receptor leads to dose-dependent hydrocephalus-related abnormalities in mice.

Authors:  Bing Lang; Bing Song; Wendy Davidson; Alastair MacKenzie; Norman Smith; Colin D McCaig; Anthony J Harmar; Sanbing Shen
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

6.  Congenital hydrocephalus and abnormal subcommissural organ development in Sox3 transgenic mice.

Authors:  Kristie Lee; Jacqueline Tan; Michael B Morris; Karine Rizzoti; James Hughes; Pike See Cheah; Fernando Felquer; Xuan Liu; Sandra Piltz; Robin Lovell-Badge; Paul Q Thomas
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

Review 7.  Blood-brain barrier and foetal-onset hydrocephalus, with a view on potential novel treatments beyond managing CSF flow.

Authors:  M Guerra; J L Blázquez; E M Rodríguez
Journal:  Fluids Barriers CNS       Date:  2017-07-13

8.  Camel regulates development of the brain ventricular system.

Authors:  Shulan Yang; Alexander Emelyanov; May-Su You; Melvin Sin; Vladimir Korzh
Journal:  Cell Tissue Res       Date:  2020-09-09       Impact factor: 5.249

9.  Mutations in KIF7 implicated in idiopathic scoliosis in humans and axial curvatures in zebrafish.

Authors:  Elizabeth A Terhune; Melissa T Cuevas; Anna M Monley; Cambria I Wethey; Xiaomi Chen; Maria V Cattell; Melisa N Bayrak; Morgan R Bland; Brittan Sutphin; George Devon Trahan; Matthew R G Taylor; Lee A Niswander; Kenneth L Jones; Erin E Baschal; Lilian Antunes; Matthew Dobbs; Christina Gurnett; Bruce Appel; Ryan Gray; Nancy Hadley Miller
Journal:  Hum Mutat       Date:  2021-02-07       Impact factor: 4.878

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.